Jørgen Ingerslev

Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM‐1VWD)

J. Goudemand, S. Lethagen, J. Eikenboom, 2008, Journal of thrombosis and haemostasis : JTH.

A novel von Willebrand disease-causing mutation (Arg273Trp) in the von Willebrand factor propeptide that results in defective multimerization and secretion.

J. Ingerslev, A. Goodeve, I. Peake, 2000, Blood.

Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWD.

A. Tosetto, J. Batlle, F. Rodeghiero, 2010, Thrombosis research.

Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM‐1VWD study

J. Goudemand, S. Lethagen, J. Eikenboom, 2009, Journal of Thrombosis and Haemostasis.

Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD

J. Goudemand, S. Lethagen, J. Eikenboom, 2006, Journal of thrombosis and haemostasis : JTH.

Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM‐1VWD)

A. Tosetto, J. Goudemand, S. Lethagen, 2007, Journal of thrombosis and haemostasis : JTH.

Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor.

J. Ingerslev, A. Goodeve, I. Peake, 2000, Blood.